CSSC Science & Technology Co Net Debt / EBITDA
The Net Debt to EBITDA of CSSC Science & Technology Co (600072.SS) as of Sep 6, 2026 is -10.79. In the previous year, Net Debt to EBITDA was 152.94 — a change of -107.05% (lower).
Get this data via API
Financial Data API
Net Debt / EBITDA
-10.79
YoY
-107.05%
Last updated:
The CSSC Science & Technology Co Net Debt / EBITDA history
3 Years
10 Years
25 Years
Max
| YEAR | Net Debt / EBITDA | YoY |
|---|---|---|
| -10.79 | -107.05% | |
| 152.94 | +164,354.95% | |
| 0.09 | -108.06% | |
| -1.15 | -108.20% | |
| 14.07 | -154.05% | |
| -26.03 | -126.36% | |
| 98.75 | +394.31% | |
| 19.98 | -168.54% | |
| -29.14 | -59.92% | |
| -72.72 | -1,131.60% | |
| 7.05 | -999.63% | |
| -0.78 | +135.94% | |
| -0.33 | -87.01% | |
| -2.56 | +8.54% | |
| -2.35 | -57.92% | |
| -5.60 | -58.06% | |
| -13.34 | -47.05% | |
| -25.20 | +3.36% | |
| -24.38 | +50.03% | |
| -16.25 | — |
CSSC Science & Technology Co Stock analysis
Frequently Asked Questions about CSSC Science & Technology Co stock
Net Debt to EBITDA of CSSC Science & Technology Co is -10.79 in 2026.
Net Debt to EBITDA of CSSC Science & Technology Co changed from 152.94 to -10.79, representing a -107.05% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Net Debt to EBITDA CSSC Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.
Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's CSSC Science & Technology Co with sector peers and the industry average to assess whether it is attractive.
Leverage — CSSC Science & Technology Co
All Key Metrics — CSSC Science & Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth